Dr. Leigh Johnson is an Associate Professor in Pharmacology and Neuroscience and Director in the Institute for Translational Research. She is an MPI of the National Institute on Aging–funded Health and Aging Brain Study: Health Disparities (HABS-HD) project, which examines biological, social, and environmental drivers of brain aging and Alzheimer’s disease. She leads the HABS-HD Disparities and Outreach Core, overseeing advisory boards, focus groups, and community engagement, and is PI of HABS-HD Project 3, studying exposome and sociocultural influences on Alzheimer’s biomarkers across the lifespan. Over her career, she has recruited more than 10,000 participants into aging research studies. She has over a decade of leadership in regulatory and compliance, including service as IRB and Research Compliance Chair. She has authored over 80 publications on Alzheimer’s disease, brain aging, biomarkers, depression, health disparities, social determinants of health, clinical trials, and community-engaged research.